Citalopram inhibits platelet function independently of SERT-mediated 5-HT transport
Abstract Citalopram prevents serotonin (5-HT) uptake into platelets by blocking the serotonin reuptake transporter (SERT). Although some clinical data suggest that selective serotonin reuptake inhibitors (SSRIs) may affect haemostasis and thrombosis, these poorly-characterised effects are not well u...
Enregistré dans:
Auteurs principaux: | Harvey G. Roweth, Ruoling Yan, Nader H. Bedwani, Alisha Chauhan, Nicole Fowler, Alice H. Watson, Jean-Daniel Malcor, Stewart O. Sage, Gavin E. Jarvis |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/03e1a156b5144db0b5daf6945d11679e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Amérique au singulier, Amériques au pluriel : à quoi nous sert la perspective hémisphérique ?
par: Elise Capredon, et autres
Publié: (2013) -
Antiplatelet effects of citalopram in patients with ischaemic stroke: A randomized, placebo-controlled, double-blind study
par: Kristian Lundsgaard Kraglund, et autres
Publié: (2019) -
Effect of microemulsions on transdermal delivery of citalopram: optimization studies using mixture design and response surface methodology
par: Huang CT, et autres
Publié: (2013) -
Hiponatremia e hipokalemia graves, recientes, asociadas a hidroclorotiazida, enalaprila y citalopram.: Caso clínico
par: Riquelme P,Arnoldo, et autres
Publié: (1999) -
Inclusion of genetic variants in an ensemble of gradient boosting decision trees does not improve the prediction of citalopram treatment response
par: Jason Shumake, et autres
Publié: (2021)